Well

Menstrual health literacy is alarmingly low – what you don’t know can harm you

Retrieved on: 
Wednesday, March 13, 2024

When I ask my menstrual health workshop participants – including clinicians – there’s usually a lot of shrugging and shaking of heads.

Key Points: 
  • When I ask my menstrual health workshop participants – including clinicians – there’s usually a lot of shrugging and shaking of heads.
  • If given multiple choice options, most think that periods either “clean the womb” or somehow “help prepare for pregnancy”.
  • Yes, the blood part can stain clothing, but there is nothing pathological, contaminating, or dangerous about periods.

So, why do we have periods?

  • Periods likely evolved as a kind of preemptive abortion, to protect women from unviable or dangerous pregnancies.
  • As a result, we have low rates of conception, high rates of miscarriage, and extremely high rates of maternal mortality in comparison to other mammals.
  • The menstrual cycle is critical for facilitation of the initial steps of this raison d’être of the female reproductive system.
  • The menstrual cycle is critical for facilitation of the initial steps of this raison d’être of the female reproductive system.

What else don’t we know?

  • Perhaps with the fact that the second phase of the cycle from ovulation to menstruation is a series of highly inflammatory processes.
  • This was only very briefly mentioned in three out of 16 textbooks.
  • We really ought to be taught from puberty how to reduce period pain and blood loss – this is not difficult science.

Why aren’t we taught this stuff?

  • My research shows that the exclusive focus on the female sex hormones in menstrual education is informed by societal influences, such as the myth of the hysterical or hormonal female.
  • This gender myth is still alive and well, although now we tend to blame the (female sex) hormones.
  • Again, there was no scientific reason for this change in focus, although it reflected existing societal beliefs about the inherently irrational behaviour of women.
  • Unfortunately, menstrual health literacy has not yet recovered from this shift in physiological models.

So what?

  • It also becomes much easier to differentiate premenstrual changes from underlying health conditions, since the latter will not be substantially alleviated by anti-inflammatory interventions alone.
  • Teaching the reductive hormonal model of the menstrual cycle unintentionally provides pseudo-scientific evidence for the damaging hormonal or hysterical female gender myth.


Sally King is the founder of Menstrual Matters- the world's first evidence-based info hub on menstrual health and rights www.menstrual-matters.com. Her doctoral research and current research fellowship were funded by the ESRC (Economic and Social Research Council).

China Hongqiao (01378.HK) Profits Surge, New Offshore Bond Issuance Expected

Retrieved on: 
Wednesday, March 13, 2024

China Hongqiao (01378.HK) Profits Surge, New Offshore Bond Issuance Expected

Key Points: 
  • China Hongqiao (01378.HK) Profits Surge, New Offshore Bond Issuance Expected
    In 2023, China's aluminum industry has witnessed significant growth, fueled by the gradual recovery of the real estate sector and the rapid expansion of the renewable energy industry.
  • The widening gap between supply and demand for electrolytic aluminum led to a rise in aluminum prices, subsequently boosting profits and profitability for China Hongqiao Group Limited(referred to as "China Hongqiao").
  • Therefore, to fulfill investors' demand for high-quality Chinese offshore assets, investment institutions are actively seeking ongoing issuance of offshore debt by China Hongqiao.
  • Currently, China Hongqiao has only two outstanding USD bonds: namely HONGQI 6.25 06/08/24 (senior bond) and HONGQI 5.25 01/25/26 (convertible bond).

China Hongqiao (01378.HK) boosts cash flow, market awaits new offshore bond issue

Retrieved on: 
Friday, March 1, 2024

Therefore, to meet investors' demand for high-quality Chinese offshore assets, investment institutions seek continued issuance of offshore debt by China Hongqiao.

Key Points: 
  • Therefore, to meet investors' demand for high-quality Chinese offshore assets, investment institutions seek continued issuance of offshore debt by China Hongqiao.
  • Currently, China Hongqiao has only two outstanding USD bonds: HONGQI 6.25 06/08/24 (senior bond) and HONGQI 5.25 01/25/26 (convertible bond).
  • With the maturity of HONGQI 6.25 06/08/24, market uncertainties arise regarding whether China Hongqiao will issue offshore bonds again.
  • However, given the current market environment and policy changes, the market is concerned about whether it will issue offshore bonds again.

ROTH to Host 36th Annual Conference March 17-19 in Dana Point, California

Retrieved on: 
Monday, March 11, 2024

NEWPORT BEACH, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- via IBN – Roth Capital Partners, LLC ("ROTH"), www.roth.com , will host its 36th Annual Conference on March 17-19, 2024, at The Ritz Carlton, Laguna Niguel, located in Dana Point, CA.

Key Points: 
  • NEWPORT BEACH, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- via IBN – Roth Capital Partners, LLC ("ROTH"), www.roth.com , will host its 36th Annual Conference on March 17-19, 2024, at The Ritz Carlton, Laguna Niguel, located in Dana Point, CA.
  • The annual ROTH Conference provides an exceptional platform for institutional investors to connect with executive management from an array of public and private growth companies.
  • We are delighted to anticipate an even more diverse range of attendees for our 36th Annual Conference," remarked Byron Roth, Executive Chairman of ROTH.
  • Sagar Sheth, CEO of ROTH, remarked, "The annual ROTH Conference is a cornerstone event, and attendees are benefiting even more from the combined expertise of MKM’s integration.

Alumis Presents Positive Data from Phase 2 Clinical Trial of ESK-001, an Oral Allosteric TYK2 Inhibitor for the Treatment of Plaque Psoriasis, at AAD Annual Meeting

Retrieved on: 
Saturday, March 9, 2024

SOUTH SAN FRANCISCO, Calif., March 09, 2024 (GLOBE NEWSWIRE) -- Alumis Inc., a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to transform the lives of patients with immune-mediated diseases, today announced the presentation of positive clinical data from a Phase 2 clinical trial of ESK-001, a highly selective allosteric tyrosine kinase 2 (TYK2) inhibitor, for the treatment of patients with moderate-to-severe plaque psoriasis. These data were presented during a late-breaking session at the American Academy of Dermatology (AAD) Annual Meeting being held March 8-12 in San Diego, California.

Key Points: 
  • These data were presented during a late-breaking session at the American Academy of Dermatology (AAD) Annual Meeting being held March 8-12 in San Diego, California.
  • The STRIDE trial enrolled 228 patients who were randomized to one of five ESK-001 dose cohorts, or placebo.
  • These data support the planned initiation of Phase 3 clinical trials of ESK-001 in moderate-to-severe plaque psoriasis in the second half of 2024.
  • “The Phase 2 clinical program was designed to evaluate the effect of different degrees of target inhibition on safety and clinical efficacy in psoriasis.

Superior Energy Services Announces Fourth Quarter 2023 Results and Conference Call

Retrieved on: 
Friday, March 8, 2024

HOUSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Superior Energy Services, Inc. (the “Company”) reported its results for the fiscal quarter and full year ended December 31, 2023.

Key Points: 
  • HOUSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Superior Energy Services, Inc. (the “Company”) reported its results for the fiscal quarter and full year ended December 31, 2023.
  • The Company’s Adjusted EBITDA (a non-GAAP measure defined on page 5) was $85.3 million for the fourth quarter of 2023 compared to $71.8 million in the third quarter of 2023.
  • U.S. offshore revenue was $96.3 million in the fourth quarter of 2023, an increase of 63% compared to revenue of $59.1 million in the third quarter of 2023.
  • Adjusted EBITDA for the fourth quarter of 2023 was $69.8 million, a 1% increase from the third quarter of 2023.

Helmets to Hardhats working to increase female representation in the skilled trades

Retrieved on: 
Friday, March 8, 2024

Helmets to Hardhats is undertaking this work with the support of the Office to Advance Women Apprentices (OAWA).

Key Points: 
  • Helmets to Hardhats is undertaking this work with the support of the Office to Advance Women Apprentices (OAWA).
  • Helmets to Hardhats expects to surpass their goal of 150 diverse registrants by the end of March 2024.
  • While Helmets to Hardhats fills career vacancies with trained, skilled, and reliable employees, they also aid in the successful transition, financial stability, and increased visibility of underrepresented groups within the skilled trades.
  • At Helmets to Hardhats, I can promote and connect other Veterans to incredible and versatile careers in the skilled trades.

Allied Energy Corporation Signs Partnership Agreement on Green Lease Project

Retrieved on: 
Thursday, March 7, 2024

CARROLLTON, Texas, March 07, 2024 (GLOBE NEWSWIRE) -- Allied Energy Corporation (OTC: AGYP) is delighted to announce the formalization of a Partnership Agreement with Petroloro LLC and ORO Energy LLC, collectively known as P&O Energy, to advance the Green Lease project.

Key Points: 
  • CARROLLTON, Texas, March 07, 2024 (GLOBE NEWSWIRE) -- Allied Energy Corporation (OTC: AGYP) is delighted to announce the formalization of a Partnership Agreement with Petroloro LLC and ORO Energy LLC, collectively known as P&O Energy, to advance the Green Lease project.
  • Under this Partnership Agreement, P&O Energy will undertake the operation of the Project by initiating a comprehensive workover program on the M1 and X3 Wells.
  • Additionally, the Partnership Agreement outlines the development of further Wells within the Project area.
  • The initial drilling location has been identified, and pending the successful acquisition of permits, Allied Energy will transfer the Project land to P&O Energy.

Goodside Health Expands Services into Pediatric Primary Health Care

Retrieved on: 
Thursday, March 7, 2024

AUSTIN & FORT WORTH, TX, March 07, 2024 (GLOBE NEWSWIRE) -- Goodside Health, a renowned leader in closing the gaps in children's healthcare, is proud to announce the expansion of their services into Pediatric Primary Health Care.

Key Points: 
  • AUSTIN & FORT WORTH, TX, March 07, 2024 (GLOBE NEWSWIRE) -- Goodside Health, a renowned leader in closing the gaps in children's healthcare, is proud to announce the expansion of their services into Pediatric Primary Health Care.
  • By stepping into Primary Care, Goodside Health aims to provide comprehensive and accessible healthcare to children with a focus on their long-term health and wellbeing.
  • Primary Care Patients can now access the care they need conveniently from any Goodside Health location, including scheduled primary care visits, walk-in urgent care available 365 days a year, on-demand telehealth services available 8am–9pm, and school-based services (where available in 1000+ Texas and Florida schools).
  • "We are thrilled to expand our services into Primary Health Care," said Brian White, CEO of Goodside Health.

Intrepid Announces Fourth Quarter and Full-Year 2023 Results

Retrieved on: 
Wednesday, March 6, 2024

Denver, CO, March 06, 2024 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. (NYSE:IPI) ("Intrepid", the "Company", "we", "us" and "our") today reports its financial results for the fourth quarter and full-year of 2023.

Key Points: 
  • Denver, CO, March 06, 2024 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. (NYSE:IPI) ("Intrepid", the "Company", "we", "us" and "our") today reports its financial results for the fourth quarter and full-year of 2023.
  • Included in the GAAP net loss figures are non-cash impairment charges of $42.8 million in the fourth quarter of 2023 and $43.3 million for the full-year 2023.
  • Adjusted EBITDA(1) of $7.1 million for the fourth quarter, bringing our full-year 2023 adjusted EBITDA to $41.6 million.
  • Intrepid generated fourth quarter and full-year 2023 sales of approximately $56.7 million and $279.1 million, respectively, which compares to fourth quarter and full-year 2022 sales of approximately $66.7 million and $337.6 million, respectively.